Types of diabetes are not limited to age groups: type 1 diabetes in
adults and type 2 diabetes in children and adolescents by Rosenbauer, Joachim et al.
Journal of Health Monitoring
Journal of Health Monitoring 2019 4(2) 29
FOCUS
Types of diabetes are not limited to age groups: type 1 diabetes in 
adults and type 2 diabetes in children and adolescents
Abstract
Based on data from the national diabetes registry DPV (Diabetes patient documentation), the diabetes registry of North 
Rhine-Westphalia and surveys conducted at hospitals and practices in Baden-Württemberg and Saxony, this study 
estimates the incidence and prevalence of type 1 diabetes in over-18-year-old adults and type 2 diabetes in 11- to 18-year-
old children and adolescents.
The national incidence of type 1 diabetes in adults was 6.1 per 100,000 person-years from 2014 to 2016, with slightly 
lower figures for women compared to men. Annually, around 4,150 adults develop type 1 diabetes. In 2016, the prevalence 
of type 1 diabetes was estimated at 493 per 100,000 persons and was lower in women at 445 per 100,000 people than 
in men at 544 per 100,000. Based on this data, there were around 341,000 adults with type 1 diabetes in 2016.
For 11- to 18-year-old children and adolescents, the national incidence of type 2 diabetes was 2.8 per 100,000 person-years 
between 2014 and 2016 and higher for girls than for boys. Annually, around 175 adolescents in this age group develop 
type 2 diabetes. The incidence estimates for Saxony were higher (4.3 per 100,000 person-years). The prevalence of type 2 
diabetes between 2014 and 2016 for 11- to 18-year-old children and adolescents was estimated between 12 and 18 cases per 
100,000 persons. During this period, there were about 950 children and adolescents of this age group with type 2 diabetes 
in Germany.
  TYPE 1 DIABETES · TYPE 2 DIABETES · INCIDENCE · PREVALENCE · DIABETES SURVEILLANCE 
1. Introduction
Diabetes mellitus means a chronic increase of glucose lev-
els in the body. From a health policy perspective, two forms 
of diabetes in particular play an important role: immune-me-
diated type 1 diabetes, which generally leads to absolute 
insulin deficiency, and type 2 diabetes, in which both insu-
lin resistance as well as reduced insulin secretion play a 
role. The disease reduces both life expectancy and quality 
of life, mainly due to chronic damage to small and large 
blood vessels. Data on the incidence and prevalence of 
diabetes, therefore, provide important information to build 
and further develop a diabetes care infrastructure.
Three regularly updated regional paediatric diabetes 
incidence registries from Baden-Württemberg, North 
Rhine-Westphalia (NRW) and Saxony, as well as the national 
DPV registry, provide sound data on the incidence of type 
1 diabetes in under-15-year-old children and adolescents. 
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were estimated for the first time for the age group up to 
55 years of age [11]. The incidence for 15- to 55-year olds was 
7.1 and 6.1, respectively, per 100,000 person-years.
A better data situation is given for type 2 diabetes in 
adulthood. A number of national and representative 
regional studies have analysed the prevalence and inci-
dence of known and unknown diabetes. Various publica-
tions present the results of these studies [3, 12, 13]. In par-
ticular, there are estimates based on the data from statutory 
health insurances and claims data from statutory health 
insurance-authorised physicians [7, 8].
For type 2 diabetes in adolescents, however, there is 
only insufficient data available. A study conducted in 
Baden-Württemberg between the years 2004 and 2005 
reported the prevalence of known type 2 diabetes in 0- to 
20-year-old children and adolescents as 2.3 per 100,000 
persons [14]. For North Rhine-Westphalia, the prevalence 
among 5- to 19-year-old children and adolescents in 2010 
was estimated at 5.8 per 100,000 persons. According to 
the study, 600 to 800 5- to 19-year-old children and ado-
lescents had a known type 2 diabetes in 2010 [15]. Accord-
ing to data from the nationwide DPV register, in the last 10 
years about 5% to 6% of children and adolescents aged 11 
to 18 years newly diagnosed with diabetes have type 2 dia-
betes [16]. Based on 2009 and 2010 statutory health insur-
ance data, the national prevalence for under-20-year-old 
girls and boys was estimated to be much higher at 30 and 
40 cases, respectively, per 100,000 persons [7]. On the 
basis of claims data from all over Germany, the prevalence 
in 2009 and 2015 for 0- to 19-year olds was estimated as 
66 and 41 cases per 100,000 persons, respectively [3]. How-
ever, it is a well-known fact that claims data leads to an 
These data sources also indicate the long-term trends for 
the incidence of type 1 diabetes in this age group [1-3]. In 
addition, the data from these three regional incidence reg-
istries feed into the European surveillance of 
type 1 diabetes within the framework of the EURODIAB 
(Epidemiology and Prevention of Diabetes) study group 
[4-6]. The project described here aims to make this data 
available for national level diabetes surveillance too.
However, only limited information is available on the inci-
dence of type 1 diabetes among adults. Based on the data 
from statutory health insurances, national prevalences 
across all age groups in 2009 and 2010 were estimated at 
300 cases per 100,000 persons [7]. Accordingly, there were 
around 256,000 persons with type 1 diabetes in Germany in 
2009 and 252,000 in 2010. Germany-wide claims data 
between 2009 and 2015 estimate similar prevalences, as well 
as a downward trend from 330 to 280 cases per 100,000 
persons [8]. Projected for the German population, around 
230,000 persons, accordingly, had type 1 diabetes in 2015. 
Reports from the disease management programs (DMP) of 
statutory health insurances estimated a significantly higher 
figure of around 311,000 persons with type 1 diabetes across 
all age groups for 2014 [9]. According to the DMP quality 
report for type 1 diabetes in Westfalen-Lippe, there were 
22,807 DMP registered patients across all age groups in 2015 
[10]. This corresponds to a prevalence of 314 per 100,000 
persons among those covered by statutory health insurance. 
Taking into account the estimated completeness of DMP in 
Westfalen-Lippe (78.4% to 89.4%), this would result in a 
prevalence of 351 to 400 per 100,000 persons [10].
Based on 2009 and 2010 statutory health insurance 
data, national age-specific incidences of type 1 diabetes 
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2.1. Definition of type 1 and type 2 diabetes
Our analysis uses the term type 1 diabetes only in the sense 
of ‘classical’ clinically diagnosed type 1 diabetes. The prac-
tice guidelines of the German Diabetes Association also 
classify patients with latent autoimmune diabetes in adults 
(LADA) as type 1 diabetes, i.e. a form of immune-mediated 
diabetes, which in most cases leads to complete insulin 
insufficiency in patients shortly after the onset of diabetes 
[17]. Diagnosing this form of diabetes requires complex 
laboratory examinations. However, an examination of all 
newly diagnosed adult diabetes patients for beta-cell anti-
bodies (indicating the immune reaction against insulin-pro-
ducing cells in the pancreas) and for C-peptide (reflecting 
the remaining insulin secretion by islet cells), is currently 
not diagnostic standard. This lack of standardisation means 
that results are only comparable to a limited extent, we 
therefore have not categorised LADA as type 1 diabetes. 
The diagnosis of type 2 diabetes is based on the German 
Diabetes Association’s current guidelines [18].
2.2  Data sources 
Table 1 provides an overview of the data sources used. To 
estimate the incidence and prevalence of type 1 diabetes 
in adults (≥ 18 years) in North Rhine-Westphalia and nation-
wide, the population-based diabetes registry of North 
Rhine-Westphalia [1] and the national DPV registry [19] were 
used as data sources.
The North Rhine-Westphalian registry has collected data 
for 0- to 14-year-old children and adolescents since 1996. 
overestimation of the prevalence, also because other forms 
of diabetes, when no insulin therapy is prescribed, are erro-
neously categorised as type 2 diabetes.
The diabetes registry of North Rhine-Westphalia pro-
vides estimates for the incidence of type 2 diabetes in chil-
dren and adolescents. Recently, an average incidence of 1.3 
per 100,000 person-years was estimated for the period 
2002 to 2014 for children and adolescents aged 5 to 19 
years, whereby the incidence between 2011 and 2014 was 
1.6 per 100,000 person-years. Accordingly, 130 to 160 per-
sons in the 5- to 19-year-old age group developed type 2 
diabetes annually. Again, based on Germany-wide claims 
data for the 2012 to 2014 period, a 15-fold higher incidence 
of 20 and 30 cases per 100,000 person-years was estimated 
for girls and boys under the age of 20, respectively. [8].
So far, a continuous provision of estimates based on a 
standardised methodology to account for the incidence 
and prevalence of type 1 diabetes across the entire adult 
age spectrum, as well as of type 2 diabetes in adolescents, 
has not been established in Germany, although such data 
would be relevant to diabetes surveillance and the further 
development of the infrastructure of health care provision. 
Precisely, because many diabetes prevention approaches 
target the group of young, at risk people, surveillance would 
need to reliably and promptly show changes in the inci-
dence in this age group. The objectives of this project in 
the context of diabetes surveillance at the Robert Koch 
Institute (RKI) were therefore to network with existing 
structures and develop supplementary structures for the 
continuous monitoring of the regional and the national 
incidence and prevalence in this group of patients.
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and data on prevalence in Baden-Württemberg (under 
20-year-olds). 
The data source in Saxony was a survey (by post, tele-
phone or e-mail) on the number of new cases of type 2 dia-
betes in children and adolescents (11 to 18 years) in 2016 
among the clinics participating in Saxony’s diabetes regis-
try (all 31 paediatric clinics) and specialised diabetological 
practices [20, 21]. 
The data source in Baden-Württemberg was a survey 
(by telephone, e-mail or fax) on the number of children and 
adolescents with type 2 diabetes (under 20 years of age) 
treated in 2016 among the participating clinics of the DIARY 
registry (Diabetes Incidence Registry in Baden-Württem-
berg, 31 paediatric clinics and one diabetes centre) [22, 23], 
the 242 members of the German association of diabetol-
ogists (BVND) in Baden-Württemberg as well as the 266 
members of the working group diabetes in Baden-Würt-
temberg (ADBW). An initial written request was made in 
July 2017, a second request in September 2017. According 
to an earlier analysis of the prevalence of type 2 diabetes 
and the available care in Baden-Württemberg, around 50% 
of type 2 diabetes patients aged under 20 years of age are 
treated in paediatric clinics, 39% by office-based diabetol-
ogists, 7% by diabetologists in clinics, 2% in clinics and 
2% in practices without diabetologists. The current survey 
of paediatric clinics and office-based diabetologists there-
fore covers around 90% of all cases.
The population data necessary to estimate incidence 
and prevalence was obtained from the Federal Statistical 
Office. Unless otherwise stated, the population data result 
from an update of the population level for 2015 on the basis 
of the 2011 census [24], since the population data for North 
It has recorded newly diagnosed cases of type 1 and type 2 
diabetes in the 0- to 34-year-old age group since 2002 based 
on three data sources: the clinic-based German Paediatric 
Surveillance Unit (ESPED), annual surveys of medical spe-
cialists working in private practices, paediatricians, general 
practitioners, as well as the national DPV registry.
The DPV initiative was started throughout Germany in 
1995 and is a computer-aided longitudinal collection of 
data on treatment of diabetes patients and outcomes. For 
the diabetes surveillance at the RKI, only the data from 
German centres (420 institutions: 181 internal medicine 
and 239 paediatric centres) was used. Data for older age 
groups is presumably far less complete, because DPV data 
collection only began in the mid 1990s and patients aged 
over 35 years in 2016 would have developed the disease 
well before 1990. 
The incidence and prevalence of type 2 diabetes in 11- to 
18-year-old children and adolescents in North Rhine-West-
phalia and at the national level was estimated by using the 
population-based diabetes registry of North Rhine-West-
phalia and the nationwide DPV registry. In addition, data 
on incidence was collected in Saxony (11- to 18-year-olds) 
Table 1
Indicators and data sources 
Own table
Indicators Data sources 
Incidence and 
prevalence of 
type 1 diabetes 
in adults




type 2 diabetes 
in children and 
adolescents
▶ Diabetes registry of North Rhine-Westphalia
▶ DPV registry
▶ Interview survey Saxony (only incidence)
▶  Interview survey Baden-Württemberg  
(only prevalence)
DPV = Diabetes patient documentation
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therefore necessary to make a plausible assumption for 
the completeness of the DPV registry for older age groups. 
The presumed completeness of ascertainment for older 
age groups was varied in terms of a sensitivity analysis. 
Incidence and prevalence with 95% confidence intervals 
(95%-CI, range in which the true value lies with 95% cer-
tainty) were estimated applying a Poisson distribution [28, 
29]. A detailed description of the methodology can be found 
in [25-29].
3.  Results 
3.1  Incidence of type 1 diabetes
Incidence of type 1 diabetes in 18- to 34-year-olds in 
North Rhine-Westphalia between 2014 and 2016 
Between 2014 and 2016, the Rhine-Westphalian diabetes 
registry recorded 391 newly diagnosed type 1 diabetes 
patients in the 18- to 34-year-old age group. This is an inci-
dence of 3.6 per 100,000 person-years. The registry cap-
tured an estimated 29.5% of the population; adjusted for 
undereporting, the incidence was therefore estimated at 
12.0 per 100,000 person-years (Table 2). Correspondingly, 
the absolute figure for new cases between 2014 and 2016 
was 1,326, i.e. an average of 442 new cases per year. Adjust-
ed for undereporting, the incidence for women was only 
about half that for men (7.9 vs. 16.1 per 100,000 per-
son-years) and the incidence was slightly higher for 18- to 
24-year-olds than for 25- to 34-year-olds (12.9 vs. 11.7 per 
100,000 person-years). Table 2 also shows the incidence 
for registered cases by age and gender.
Rhine-Westphalia (and Baden-Württemberg) were not yet 
available for 2016 at the time of the analysis. This also 
applies to the calculations for person years 2014 to 2016, 
which are based on 2014 and two times on 2015.
2.3  Statistical methods
The recording of new cases of diabetes by the registry of 
North Rhine-Westphalia, which is based on three data 
sources, allows estimating the completeness of the data 
collected by applying capture-recapture methods. Thereby, 
the proportion of patients who appear in more than one 
data source allows an estimate of the number of patients 
who were not recorded. Subsequently, the figures can then 
be adjusted. To estimate the completeness of the data col-
lected, a suitable statistical model was adapted to the data 
(log-linear model that accounts for overdispersion) [25, 26]. 
After applying a standard statistical criterion (AICC [27]), 
the model was chosen that best describes the available 
registry data. Both the completeness of the registry in gen-
eral and, in addition, of the DPV database was estimated.
Estimates regarding the completeness of the North 
Rhine-Westphalia registry were used to calculate estimates 
corrected for underreporting for the incidence and preva-
lence in North Rhine-Westphalia from the data observed 
in the North Rhine-Westphalia registry. Estimates for the 
completeness of the DPV data basis for North Rhine-West-
phalia were used to calculate ascertainment corrected esti-
mates of incidence and prevalence for Germany in national 
DPV data. Based on the North Rhine-Westphalia and DPV 
registries, completeness of ascertainment could only 
be estimated for the 18- to 34-year-old age group; it was 
Currently, around 4,150 
adults and 3,100 children 
and adolescents (aged 0 to 17) 
develop type 1 diabetes 
annually.
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(Table 2). The ascertainment rate of DPV for the 18- to 34-year-
old age group was estimated at 17.2% based on the North 
Rhine-Westphalia registry. Assuming that DPV has the 
same capture rate in older age groups too, the incidence 
in the age group 18 years and older adjusted for undere-
porting was estimated as 6.1 per 100,000 person-years. 
Incidence of type 1 diabetes in adults over 18 years of age 
in Germany between 2014 and 2016
Between 2014 and 2016, 2,144 patients at least 18 years of 
age were registered in the DPV diabetes registry with newly 
diagnosed type 1 diabetes. Against 205,986,915 person-years 
[31], this is an incidence of 1.0 per 100,000 person-years 
Study population 2014 - 2016
Incident cases Incidence (95% CI)1
Registered CR2 Adjusted3,4 Registered5 Adjusted3
North Rhine-Westphalia 18-34 years
Total 391 29.5% 1,326 3.6 (3.2-3.9) 12.0 (11.4-12.7)
Women 138 32.6% 423 2.6 (2.2-3.1) 7.9 (7.2-8.7)
Men 253 27.8% 911 4.5 (3.9-5.1) 16.1 (15.1-17.2)
18-24 years 184 32.3% 569 4.2 (3.6-4.8) 12.9 (11.9-14.0)
25-34 years 207 26.8% 772 3.2 (2.7-3.6) 11.7 (10.9-12.5)
Germany ≥18 years
Total 2,144 17.2%6 12,495 1.0 (1.0-1.1) 6.1 (6.0-6.2)
Women 895 15.7%6 5,685 0.9 (0.8-0.9) 5.4 (5.3-5.5)
Men 1,249 21.3%6 5,857 1.2 (1.2-1.3) 5.8 (5.7-6.0)
18-24 years 436 17.2% 2,541 2.3 (2.1-2.5) 13.5 (12.9-14.0)
25-34 years 546 17.2% 3,182 1.7 (1.6-1.9) 10.1 (9.8-10.5)
35-44 years 367 17.2%7 2,139 1.2 (1.1-1.4) 7.2 (6.9-7.5)
45-54 years 384 17.2%7 2,238 1.0 (0.9-1.1) 5.6 (5.3-5.8)
55-64 years 226 17.2%7 1,317 0.7 (0.6-0.8) 3.9 (3.7-4.1)
65-74 years 122 17.2%7 711 0.5 (0.4-0.6) 2.9 (2.6-3.1)
≥75 years 63 17.2%7 367 0.2 (0.2-0.3) 1.4 (1.2-1.5)
CR  = coverage rate, ESPED = German Paediatric Surveillance Unit, DPV = diabetes patient documentation,  
AICC = Akaike information criterion, adjusted version for small samples, CI = Confidence interval
1  per 100,000 person-years
2  Estimated coverage rate based on capture-recapture analysis using three sources of data (ESPED, practices, DPV) according to best log linear model based on 
AICC criterion with main effects ESPED, practices and DPV for models of incidence and prevalence, and interactions ESPED*practices and ESPED*DPV for 
prevalence models for the data from the diabetes registry North Rhine-Westphalia (type 1 diabetes 18- to 34-years-old, type 2 diabetes 11- to 18-years-old)
3  Adjusted according to the estimated underreporting
4  The sum of adjusted case numbers for both genders and/or age groups may not correspond to the adjusted case number for the total group because the number 
of cases is estimated based on different log linear models
5  Estimated based on registered number of cases
6  Estimated as sum of all captured cases across all age groups divided by the sum of all cases adjusted by under-coverage for all age groups
7  Assumed DPV coverage rate according to the 18- to 34-year-old age group
Table 2 
Incidence and prevalence 
of type 1 diabetes in Germany
Source: Diabetes registry of North Rhine-West-
phalia, Diabetes patient documentation 
(DPV registry) [1, 19] Continued on next page
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Study population 2016 (2015, 2014)
Prevalent cases Prevalence (95% CI)1
Registered CR2 Adjusted3,4 Registered5 Adjusted3
North Rhine-Westphalia 18-34 years
Total 11,284 72.5% 15,554 303.8 (298.3-309.5) 418.8 (412.3-425.4)
10,803 70.4% 15,352 290.9 (285.4-296.4) 413.4 (406.9-420.0) (2015)
10,291 67.2% 15,313 286.6 (281.1-292.2) 426.4 (419.7-433.2) (2014)
Women 5,123 72.9% 7,030 285.7 (277.9-293.6) 392.1 (382.9-401.3)
Men 6,161 72.5% 8,499 320.8 (312.8-328.9) 442.5 (433.1-452.0)
18-24 years 5,099 88.6% 5,754 344.1 (334.7-353.7) 388.3 (378.4-398.5)
25-34 years 6,185 59.6% 10,379 277.1 (270.2-284.1) 465.0 (456.1-474.0)
Germany ≥18 years
Total 83,215 24.4%6 340,664 120.5 (119.7-121.3) 493.3 (491.7-495.0)
79,812 24.1%6 331,203 115.9 (115.1-116.7) 481.1 (479.4-482.7) (2015)
76,450 23.6%6 324,393 112.3 (111.5-113.1) 476.4 (474.8-478.1) (2014)
Women 38,733 24.7%6 157,063 109.7 (108.6-110.8) 445.0 (442.8-447.2)
Men 44,582 24.2%6 183,446 131.8 (130.6-133.0) 543.5 (541.0-546.0)
18-24 years 21,259 79.1% 26,879 336.1 (331.6-340.6) 425.0 (419.9-430.0)
25-34 years 22,978 42.6% 53,932 217.0 (214.2-218.4) 509.4 (505.1-513.7)
35-44 years 10,131 15.0%7 67,540 102.5 (100.5-104.5) 683.6 (678.4-688.8)
45-54 years 9,702 15.0%7 64,680 73.3 (71.8-74.7) 488.4 (484.6-492.1)
55-64 years 8,072 15.0%7 53,813 70.2 (68.6-71.7) 467.8 (463.8-471.7)
65-74 years 5,229 15.0%7 34,860 63.6 (61.9-65.4) 424.2 (419.7-428.6)
≥75 years 5,844 15.0%7 38,960 62.9 (61.3-64.5) 419.3 (415.3-423.5)
CR  = coverage rate, ESPED = German Paediatric Surveillance Unit, DPV = diabetes patient documentation,  
AICC = Akaike information criterion, adjusted version for small samples, CI = Confidence interval
1  per 100,000 persons
2  Estimated coverage rate based on capture-recapture analysis using three sources of data (ESPED, practices, DPV) according to best log linear model based on 
AICC criterion with main effects ESPED, practices and DPV for models of incidence and prevalence, and interactions ESPED*practices and ESPED*DPV for 
prevalence models for the data from the diabetes registry North Rhine-Westphalia (type 1 diabetes 18- to 34-years-old, type 2 diabetes 11- to 18-years-old)
3  Adjusted according to the estimated underreporting
4  The sum of adjusted case numbers for both genders and/or age groups may not correspond to the adjusted case number for the total group because the number 
of cases is estimated based on different log linear models
5  Estimated based on registered number of cases
6  Estimated as sum of all captured cases across all age groups divided by the sum of all cases adjusted by under-coverage for all age groups
7  Assumed DPV coverage rate according to the 18- to 34-year-old age group
Table 2 Continued 
Incidence and prevalence 
of type 1 diabetes in Germany
Source: Diabetes registry of North Rhine-West-
phalia, Diabetes patient documentation 
(DPV registry) [1, 19]
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3.2  Prevalence of type 1 diabetes
Prevalence of type 1 diabetes in 18- to 34-year-olds in 
North Rhine-Westphalia between 2014 and 2016
In 2016, 11,285 patients with type 1 diabetes aged 18 to 34 
years were registered in the North Rhine-Westphalian dia-
betes registry. Against a total population of 3,713,823 [31], 
the prevalence was 303.8 per 100,000 persons (Table 2). 
The estimated coverage rate was 72.5%, and the 
underreporting-adjusted prevalence was therefore estimat-
ed at 418.8 per 100,000 persons. Accordingly, in 2016, 
around 15,554 adults in the 18- to 34-year-old age group 
had type 1 diabetes in North Rhine-Westphalia. Adjusted 
for underreporting, the prevalence was 426.4 per 100,000 
persons in 2014 and 413.4 per 100,000 persons in 2015. 
In 2016, the underreporting-adjusted prevalence for wom-
en was around 12% to 13% lower than for men (392.1 vs. 
442.5 per 100,000 persons, Figure 1) and the adjusted 
prevalence was significantly higher for 25- to 34-year-olds 
compared to 18- to 24-year-olds (465.0 vs. 388.3 per 
Accordingly, there was an absolute number of 12,495 new 
cases between 2014 and 2016, i.e. an average of 4,165 new 
cases per year. Assuming a completeness of DPV in the age 
group over 35 years of 22.2% or 12.2% (17.2±5%), this gives 
an adjusted incidence estimate of 5.3 (95% CI 5.2-5.4) or 7.4 
(95% CI 7.3-7.5) per 100,000 person-years. The absolute 
number of new cases was then estimated as 3,653 and 5,082.
The incidence adjusted for undereporting of type 1 dia-
betes was slightly lower for women compared to men (5.4 
vs. 5.8 per 100,000 person-years) and decreased continu-
ously with age, from 13.5 per 100,000 person-years in 18- 
to 24-year-olds to 1.4 per 100,000 person-years in the group 
aged at least 75. Table 2 moreover shows the incidence for 
registered cases by age and gender as well as correspond-
ing estimates of ascertainemnet rates and incidences.
Incidence and number of new cases of type 1 diabetes 
among children and adolescents aged 0 to 17 years in 
Germany
To provide a fuller picture, we include previously published 
figures on paediatric type 1 diabetes patients. According to 
current estimates from North Rhine-Westphalia, the inci-
dence for type 1 diabetes in the 0- to 17-year-old age group 
is 23.6 per 100,000 person-years, so that for Germany we 
can assume a figure of 3,100 new cases of type 1 diabetes 
annually [30].
Total number of new cases of type 1 diabetes for Germa-
ny (all age groups)
Based on these estimates, annually, around 7,265 persons 









North Rhine-Westphalia 2016 Germany 2016
Prevalence of type 1 diabetes
Around 341,000 adults  
and 32,000 children and 




of type 1 diabetes according to gender 
in the age groups 18 to 34 years 
(North Rhine-Westphalia) 
and 18 years and older (projected for Germany)
Source: Diabetes registry of North Rhine- 
Westphalia, Diabetes patient documentation 
(DPV registry) [1, 19]
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Prevalence and number of children and adolescents aged 
0 to 17 years with type 1 diabetes in Germany
According to current estimates from North Rhine-West-
phalia, the prevalence of type 1 diabetes in the 0- to 17-year-
old age group was 240 per 100,000 persons, which means 
that around 32,000 children and adolescents in Germany 
had type 1 diabetes [32].
Total number of persons with type 1 diabetes in Germany
Based on these estimates, the total number of type 1 dia-
betes patients across all age groups in Germany is current-
ly almost 373,000.
3.3  Incidence of type 2 diabetes in children and adoles-
cents
Incidence of type 2 diabetes in children and adolescents 
aged 11 to 18 years in North Rhine-Westphalia between 
2014 and 2016
Between 2014 and 2016, 105 patients with newly diagnosed 
type 2 diabetes aged 11 to 18 years were registered in the 
North Rhine-Westphalian diabetes registry. Against a total 
of 4,308,426 person-years, the incidence was 2.4 per 
100,000 person-years (Table 3). The registry coverage rate 
was 71.9%, and the estimated underreporting-adjusted 
incidence, correspondingly, 3.4 per 100,000 person-years. 
Accordingly, there were an absolute number of 146 new 
cases between 2014 and 2016, which is an average annual 
incidence of 49 cases. For girls, the underreporting-adjust-
ed incidence rate was over 60% higher than for boys (4.2 
vs. 2.6 per 100,000 person-years). No significant difference 
was found between the 11- to 14-year-old and the 15- to 18 
100,000 persons). Furthermore, Table 2 shows the preva-
lence for registered cases by age and gender as well as the 
corresponding coverage rates and prevalence estimates.
Prevalence of type 1 diabetes in adults over 18 years of 
age in Germany between 2014 and 2016
In 2016, 83,215 patients with type 1 diabetes aged 18 years or 
older were registered in the DPV diabetes registry. Against a 
population of 69,051,391 (as at 31.12.2016) [31], the prevalence 
was 120.5 per 100,000 persons (Table 2). The coverage rate 
of DPV in the 18- to 24 and 25- to 34-year-old age group was 
estimated as 79.1% and 42.6%, respectively. Assuming a DPV 
coverage rate of 15% in the higher age groups, a prevalence 
of 493.3 per 100,000 persons was estimated for the age group 
of 18 years or older in 2016. For 2015 and 2014, the underre-
porting-adjusted prevalence was 481.1 and 476.4 per 100,000 
persons, respectively. Correspondingly, in 2016, 340,664 
adults had type 1 diabetes in Germany. Assuming a DPV 
coverage rate of the age group over 35 years of 20% and 10%, 
respectively, an adjusted prevalence estimate of 399.3 
(95% CI 397.8-400.8) and 681.5 (95% CI 679.6-683.5) per 
100,000 persons resulted for 2016. The absolute number of 
adults with type 1 dia betes was then estimated to be 275,701 
and 470,591, respectively, in 2016.
The underreporting-adjusted prevalence in 2016 was 
around 18% lower for women than for men (445.0 vs. 543.5 
per 100,000 persons, Figure 1). Moreover, in 2016, the 
underreporting-adjusted prevalence rose from 425.0 per 
100,000 persons in the 18- to 24-year-old age group to 
683.6 per 100,000 persons in the 35- to 44-year-old age 
group and then decreased with age continuously to 419.3 
per 100,000 persons aged 75 and over (Table 2).
Currently, about 175 children 
and adolescents aged  
11 to 18 years develop  
type 2 diabetes annually.
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Incidence of type 2 diabetes in children and adolescents 
aged 11 to 18 years in Saxony in 2016
The 2017 interview surveys in Saxony achieved response 
rates of 100% among paediatric hospitals (n=31) and 88.1% 
among diabetological practices (n=119). In 2016, ten new 
cases of type 2 diabetes were registered, three cases in 
paediatric clinics and seven in diabetological practices. 
year-old age group (3.5 vs. 3.3 per 100,000 person-years). 
Table 3 also shows the incidence for registered cases by age 
and gender, as well as the corresponding estimates of cov-
erage rates and incidences.
Study population 2014-2016
Incident cases Incidence (95% CI)1
Registered CR2 Adjusted3,4 Registered5 Adjusted3
North Rhine-Westphalia 11-18 years
Total 105 71.9% 146 2.4 (2.0-3.0) 3.4 (2.9-4.0)
Girls 63 72.4% 87 3.0 (2.3-3.9) 4.2 (3.4-5.2)
Boys 42 72.4% 58 1.9 (1.4-2.6) 2.6 (2.0-3.4)
18-24 years 53 74.6% 71 2.6 (2.0-3.4) 3.5 (2.7-4.4)
25-34 years 52 69.2% 75 2.3 (1.7-3.0) 3.3 (2.6-4.1)
Saxony 11-18 years
10 90.9%6 11 4.0 (1.5-6.4) 4.3 (1.8-6.9) (2016)
21 84.0%6 25 4.2 (2.4-6.1)  5.1 (3.1-7.1) (2014/2015)7
Germany 11-18 years
Total 273 51.6% 529 1.5 (1.3-1.6) 2.8 (2.6-3.1)
Girls 172 55.1% 312 1.9 (1.6-2.2) 3.4 (3.1-3.9)
Boys 101 45.7% 221 1.1 (0.9-1.3) 2.3 (2.0-2.6)
11-14 years 81 57.7% 140 0.9 (0.7-1.1) 1.6 (1.3-1.9)
15-18 years 192 49.3% 389 2.0 (1.7-2.3) 4.0 (3.6-4.4)
CR  = coverage rate, ESPED = German Paediatric Surveillance Unit, DPV = diabetes patient documentation,  
AICC = Akaike information criterion, adjusted version for small samples, CI = Confidence interval
1  per 100,000 person-years
2  Estimated coverage rate based on capture-recapture analysis using three sources of data (ESPED, practices, DPV) according to best log linear model based on 
AICC criterion with main effects ESPED, practices and DPV for models of incidence and prevalence, and interactions  ESPED*practices and ESPED*DPV for 
prevalence models for the data from the diabetes registry North Rhine-Westphalia (type 1 diabetes 18- to 34-years-old, type 2 diabetes 11- to 18-years-old)
3  Adjusted according to the estimated underreporting
4  The sum of adjusted case numbers for both genders and/or age groups may not correspond to the adjusted case number for the total group because the number 
of cases is estimated based on different log linear models.
5  Estimated based on registered number of cases
6 Response rate for surveys of paediatric and diabetological practices in Saxony
7 Estimated total coverage rate by [14]
Table 3
Incidence and prevalence of type 2 diabetes 
in Germany
Source: Baden-Württemberg DIARY 
(Diabetes Incidence Registry), diabetes registry 
of North Rhine-Westphalia, diabetes registry of 
Saxony, Diabetes patient documentation 
(DPV registry) [1, 19-23] Continued on next page
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an incidence – adjusted for the estimated coverage rate  – 
of 5.1 per 100,000 person-years.
Against a total of 252,919 person-years, this was an inci-
dence of 4.0 per 100,000 person-years (Table 3). Adjusted 
for the response rate, the incidence was 4.3 per 100,000 
person-years. For 2014 to 2015, previous surveys estimated 
Study population 2016 (2015, 2014)
Prevalent cases Prevalence (95% CI)1
Registered CR2 Adjusted3,4 Registered5 Adjusted3
North Rhine-Westphalia 11-18 years
Total 150 77.3% 194 10.4 (8.8-12.2) 13.5 (11.7-15.5)
167 76.6% 218 11.6 (9.9-13.5) 15.2 (13.2-17.3) (2015)
165 78.2% 211 11.5 (9.8-13.4) 14.7 (12.8-16.9) (2014)
Girls 91 76.5% 119 13.1 (10.6-16.1) 17.2 (14.2-20.6)
Boys 59 78.7% 75 7.9 (6.0-10.2) 10.1 (7.9-12.6)
11-14 years 30 71.4% 42 4.5 (3.0-6.4) 6.2 (4.5-8.4)
15-18 years 120 78.4% 153 15.7 (13.0-18.8) 20.0 (17.0-23.5)
Baden-Württemberg <20 years
80 90.0%6 89 3.8 (3.0-4.6) 4.2 (3.4-5.2) (2016)
50 90.0%6 56 2.4 (1.8-3.1) 2.7 (2.0-3.5) (2015)6
Germany 11-18 years
Total 445 58.7% 758 7.1 (6.5-7.8) 12.2 (11.3-13.0)
554 57.2% 968 8.8 (8.1-9.5) 15.4 (14.4-16.3) (2015)
652 57.4% 1,136 10.5 (9.7-11.3) 18.2 (17.2-19.3) (2014)
Girls 273 60.4% 452 9.1 (8.0-10.2) 15.1 (13.7-16.5)
Boys 172 55.8% 308 5.3 (4.5-6.1) 9.6 (8.5-10.6)
11-14 years 106 54.8% 194 3.6 (2.9-4.3) 6.6 (5.6-7.5) 
15-18 years 339 60.1% 564 10.4 (9.3-11.5) 17.2 (15.8-18.7)
CR  = coverage rate, ESPED = German Paediatric Surveillance Unit, DPV = diabetes patient documentation,  
AICC = Akaike information criterion, adjusted version for small samples, CI = Confidence interval
1  per 100,000 persons
2  Estimated coverage rate based on capture-recapture analysis using three sources of data (ESPED, practices, DPV) according to best log linear model based on 
AICC criterion with main effects ESPED, practices and DPV for models of incidence and prevalence, and interactions  ESPED*practices and ESPED*DPV for 
prevalence models for the data from the diabetes registry North Rhine-Westphalia (type 1 diabetes 18- to 34-years-old, type 2 diabetes 11- to 18-years-old)
3  Adjusted according to the estimated underreporting
4  The sum of adjusted case numbers for both genders and/or age groups may not correspond to the adjusted case number for the total group because the number 
of cases is estimated based on different log linear models.
5  Estimated based on registered number of cases
6 Estimated total coverage rate by [14]
Table 3 Continued
Incidence and prevalence of type 2 diabetes 
in Germany
Source: Baden-Württemberg DIARY 
(Diabetes Incidence Registry), diabetes registry 
of North Rhine-Westphalia, diabetes registry of 
Saxony, Diabetes patient documentation 
(DPV registry) [1, 19-23]
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estimated at 13.5 per 100,000 persons. For 2015, the under-
reporting-adjusted prevalence was 15.2, and for 2014 14.7 
per 100,000 persons. Accordingly, in 2016, 194 11- to 
18-year-old children and adolescents had diagnosed type 2 
diabetes, 218 in 2015 and 211 in 2014. In 2016, the under-
reporting-adjusted prevalence was 70% higher for girls 
than for boys (17.2 vs. 10.1 per 100,000 persons) and 
around three times higher for 15- to 18-year-olds compared 
to 11- to 14-year-olds. Table 3 also shows the prevalence for 
recorded cases by age and gender as well as the corre-
sponding coverage rates and prevalence estimates.
Prevalence of type 2 diabetes in children and adolescents 
under 20 years of age in Baden-Württemberg
In the 2017 survey in Baden-Württemberg, the response 
rate for the paediatric DIARY network (31 paediatric clinics 
and 1 diabetes centre) was 78.1% (25/32) and for diabetol-
ogists caring for adults 21.4% (57/266) (BVND 14.5% 
(35/242), ADBW 8.3% (22/266)). 
In 2016, a total of 80 patients with type 2 diabetes under 
the age of 20 years were recorded in Baden-Württemberg 
(Table 3), 34 patients in the DIARY network, i.e. in paedi-
atric care, 26 BVND patients and 20 patients in the regional 
ADBW association. For a population of 2,097,929 children 
and adolescents [31], this is a prevalence of 3.8 per 100,000 
persons. Taking account of the estimated 90% coverage 
rate provides a prevalence of 4.2 per 100,000 persons. 
A previous estimate had reported a lower prevalence of 2.4 
(95% CI 1.8-3.1) and a lower adjusted prevalence of 2.7 (95% 
CI 2.0-3.5) per 100,000 persons.
Incidence of type 2 diabetes in children and adolescents 
aged 11 to 18 years in Germany between 2014 and 2016
Between 2014 and 2016, 273 patients with newly diagnosed 
type 2 diabetes aged 11 to 18 years were registered in the 
DPV diabetes registry. With a total of 18,774,057 per-
son-years [31], this resulted in an incidence of 1.5 per 
100,000 person-years (Table 3). The DPV coverage rate was 
51.6%, so that a underreporting-adjusted incidence of 2.8 
per 100,000 person-years was estimated. Accordingly, there 
was an absolute number of 529 new cases between 
2014 and 2016, i.e. an average of 176 new cases per year. 
Adjusted for underreporting, the incidence for girls was 
50% higher than for boys (3.4 vs. 2.3 per 100,000 person- 
years). Adjusted for underreporting, the incidence in the 
15- to 18-year-old age group was 2.5 times higher than in 
the 11- to 14-year-old age group (4.0 vs. 1.6 per 100,000 
person-years). Table 3 moreover shows the incidence for 
recorded cases by age and gender, as well as correspond-
ing estimates of coverage rates and incidences.
3.4  Prevalence of type 2 diabetes in children and adoles-
cents 
Prevalence of type 2 diabetes in children and adolescents 
aged 11 to 18 years in North Rhine-Westphalia between 
2014 and 2016
In 2016, 150 patients with type 2 diabetes aged 11 to 18 years 
were registered in the diabetes registry of North Rhine-West-
phalia. For a population of 1,437,776 adolescents of this 
age group [31], this is a prevalence of 10.4 per 100,000 per-
sons (Table 3). The estimated coverage rate was 77.3%, and 
the underreporting-adjusted prevalence was therefore 
Around 950 children and 
adolescents aged 11 to 18 
years have type 2 diabetes.
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For the first time, current estimates for the incidence of 
type 1 diabetes across all age groups for adults aged over 
18 are provided. For young adults aged 18 to 34 years, the 
incidence estimates from North Rhine-Westphalia fit well 
to national incidence figures (12.0 vs. 11.8 per 100,000 per-
son-years). For the group of all adults (aged over 18) a low-
er incidence of an estimated 6.1 per 100,000 person-years 
was found, which reflects the decreasing incidence of 
type 1 diabetes with age. Statutory health insurance data 
provides a similar incidence, yet only for the limited age 
ranges 15 to 55 (7.1 per 100,000 person-years) and 20 to 55 
(6.1 per 100,000 person-years) [11]. As the incidence of 
type 1 diabetes decreases with age, the incidence estimates 
for all adults based on statutory health insurance data 
should be lower.
According to the current prevalence estimate (493 per 
100,000 persons), about 341,000 adults at the age of at 
least 18 years are affected by type 1 diabetes at the national 
level. This estimate is higher than previous ones based on 
statutory health insurance data. According to the reports 
of the structured treatment programs run by statutory 
health insurances (DMP programs), there were around 
279,000 type 1 diabetes patients over 18 years of age in 
Germany in 2014 [9]. Prevalence estimates based on stat-
utory health insurance data estimated that there were 
229,000 adults aged over 20 with type 1 diabetes in Ger-
many in 2009 and 224,000 in 2010. Prevalences calculated 
on the basis of claims data yielded 262,000 type 1 diabetes 
Prevalence of type 2 diabetes in children and adolescents 
aged 11 to 18 years in Germany between 2014 and 2016
In 2016, 445 patients with type 2 diabetes aged 11 to 18 
years were registered in the DPV diabetes registry. Against 
a population of 6,237,040 children and adolescents (as at 
31.12.2016) [31], this is a prevalence of 7.1 per 100,000 
(Table 3). Coverage rate was an estimated 58.7%, giving an 
estimated underreporting-adjusted prevalence of 12.2 per 
100,000 persons. The underreporting-adjusted prevalence 
was 15.4 for 2015 and 18.2 per 100,000 persons for 2014. 
Accordingly, in 2016, 758 11- to 18-year-old children and 
adolescents had type 2 diabetes. In 2014 and 2015, it was 
1,136 and 968 children and adolescents, respectively, i.e. 
an average of around 950 children and adolescents in the 
years 2014 to 2016. In 2016, the underreporting-adjusted 
prevalence was nearly twice as high for girls compared to 
boys (15.1 vs. 9.6 per 100,000 persons, Figure 2) and 
around 2.5 times higher for 15- to 18-year-olds compared 
to 11- to 14-year-olds. Table 3 also shows the prevalence for 
recorded cases by age and gender as well as the corre-








North Rhine-Westphalia 2016 Germany 2016
Prevalence of type 2 diabetes
Incidence and prevalence of 
type 1 diabetes is lower in 
women than in men.
Figure 2
Underreporting-adjusted prevalence 
of type 2 diabetes according to gender 
in the age group 11 to 18 years
Source: Diabetes registry of North Rhine- 
Westphalia, Diabetes patient documentation
(DPV registry) [1, 19]
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surveillance at the RKI. Both DIARY clinics, all ADBW (work-
ing group diabetes in Baden-Württemberg) members, as 
well as the BVND (German association of diabetologists) 
in Baden-Württemberg took part in the survey. 
The first prevalence survey in Baden-Württemberg was 
conducted between 2004 and 2006 and indicated a preva-
lence of 2.4 per 100,000 persons (95% CI 1.7-3.1) for the 
age group under 20 years. For 2015, the prevalence was 
2.3 per 100,000 persons (95% CI 1.7-2.9). During a ten year 
period, the prevalence of type 2 diabetes in adolescents 
therefore remained stable [14]. An update within the con-
text of this sub-project of the national diabetes surveillance 
showed a prevalence of 2.4 (adjusted for undereporting 
2.7) for 2015 for 100,000 persons, yet a significantly higher 
prevalence of 3.8 (adjusted for underreporting 4.2) per 
100,000 persons for 2016.
Point estimates for the incidence of type 2 diabetes vary 
significantly for North Rhine-Westphalia, Saxony and Ger-
many overall, yet taking into account the uncertainty of 
estimates relativises these differences. All current estimates 
are higher than the average incidence in North Rhine-West-
phalia between 2002 and 2014, a fact which indicates an 
increase in the rate of new cases. The incidence between 
2012 and 2014 for under-20-year-olds estimated on the 
basis of claims data is many times higher [8]. Presumably 
this is due to the differences in forms of data collection 
and different case definitions. The observed changes to the 
incidence in Saxony are probably related to random fluctu-
ations in incidence of this ultimately rare disease, as well 
as the potential factor of differences in the quality of data 
collection. Due to the great uncertainty of estimates (broad 
confidence intervals), evidence for incidence changes is 
patients in 2009 and 230,000 in 2015 [3]. However, because 
they fail to account for the privately insured – around 10% 
of the population – incidence and prevalence estimates 
based on statutory health insurance data most likely under-
estimate the true number of cases.
Combined with estimates for the 0- to 17-year-old age 
group, there are around 7,250 new cases of type 1 diabetes 
annually in Germany and there is a total of about 373,000 
type 1 diabetes patients.
Type 2 diabetes
At the turn of the millennium, reports on a significant 
increase of cases of type 2 diabetes at adolescent age began 
to multiply. Such reports came mainly from North Ameri-
ca and Asia, and were based on an increase in the obesity 
prevalence in this age group [33, 34]. This was contrasted 
by European surveys, which pointed at a significantly low-
er prevalence of type 2 diabetes in adolescents [14, 35-37]. 
Between 2004 and 2006, the first comprehensive 
cross-sectional study of type 2 diabetes among children 
and adolescents was conducted in Baden-Württemberg 
[14]. With its population of 10.7 million, of which 22.7% are 
under 20 years of age, Baden-Württemberg is the third larg-
est federal state. With the DIARY network (Diabetes Inci-
dence Registry), Baden-Württemberg has a federal state 
wide comprehensive surveying structure that binds in all 
paediatric clinics in the state, as well as one diabetes cen-
tre. The first cross-sectional survey was conducted within 
the framework of this network and with the participation 
of internal medicine clinics and diabetological practices. 
In 2016, ten years later, a new cross-sectional survey was 
conducted as a sub-project with the national diabetes 
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neighbouring countries such as Sweden [36], the UK [35] 
or Austria [37]. Compared to North America and Asia, 
type 2 diabetes among children and adolescents therefore 
remains a (still) relatively rare disease in Germany [39].
While the observed regional differences in the incidence 
and prevalence of type 2 diabetes among children and ado-
lescents may point to actual regional differences, they could 
also be related to differences in surveying methods and 
coverage rates. Regional differences in the disease rate of 
type 2 diabetes among adults, in particular a North-South 
and an East-West gradient have been described by the 
DIAB-CORE (Diabetes-Collaborative Research of Epidemi-
ologic Studies) project of the diabetes competency network 
and secondary analyses of statutory health insurance data 
[8, 40, 41]. Type 2 diabetes, as well as the key risk factor 
obesity, are closely tied to individual social status and 
regional levels of deprivation [42-44]. However, differences 
in surveying methods and the quality of data collection also 
influence incidence and prevalence estimates. In North 
Rhine-Westphalia, more than 20% of patients were found 
in general practitioners' practices, a care level that was not 
comprehensively covered by the survey in Baden-Württem-
berg. Due to local and historical specificities, there are dif-
ferences in the diabetological treatment patients receive 
depending on whether they are living in Baden-Württem-
berg, Saxony or North Rhine-Westphalia.
4.2 Limitations
Type 1 diabetes
The analyses only took into account patients with a medi-
cal diagnosis of ‘classical’ type 1 diabetes. In routine care, 
lacking and results from longer periods of observation are 
to be seen.
Point estimates for the prevalence of type 2 diabetes in 
North Rhine-Westphalia, Baden-Württemberg and Germany 
overall likewise show substantial discrepancies. Particularly 
notable is the low prevalence in Baden-Württemberg 
(2015/2016: 2.4/3.8 and adjusted for underreporting 2.7/4.2 
per 100,000 persons) compared to North Rhine-Westphalia 
and nationwide estimates (12 – 18 per 100,000 persons). 
Based on statutory health insurance data, the estimates for 
the prevalence for under-20-year-olds were many times 
higher. For 2009 to 2010, the prevalence was estimated as 
30 to 40 per 100,000 persons [7]. Age-specific estimates 
reported in [8] provided an estimated prevalence of 66 or 
41 per 100,000 persons for 2009 and 2015, respectively. 
The great discrepancy with regard to other surveys is pre-
sumably linked to differences in surveying methods and a 
different classification of type 2 diabetes.
All data sources point to a higher number of female 
adolescent type 2 diabetes cases. Higher body fat and a 
lower insulin sensitivity, as well as lower levels of physical 
activity among obese female children and adolescents 
could play a causal role here.
The fact that the frequency of type 2 diabetes in this age 
group in central Europe is far lower than for example in 
North America can be explained by the ethnic composition 
of the population. People of Afro-American and Hispan-
ic-American background, from Asia and the Pacific Islands, 
as well as Native Americans have a significantly higher 
type 2 diabetes risk and are not an important proportion 
of the European population [38]. The prevalence rates found 
in Baden-Württemberg are comparable to those found in 
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Rhine-Westphalia registry 2002). Assumptions on the cov-
erage rate of the DPV registry used could lead to distor-
tions of national incidence and prevalence estimates. In 
terms of a sensitivity analysis, however, the assumptions 
regarding the completeness of capture were varied.
Type 2 diabetes
The registries only include diagnosed cases of type 2 dia-
betes in children and adolescents. They therefore estimate 
only the incidence and prevalence of known type 2 dia betes. 
However, a significant number of undiagnosed cases can-
not be ruled out, though precise estimates for children and 
adolescents do not exist. For adulthood, a proportion of 
unknown type 2 diabetes in the total prevalence of 20% to 
50% has been reported [45]. Moreover, a clear distinction 
between type 2 diabetes and monogenetic diabetes forms 
is not always easy in children and adolescents, which may 
lead to erroneous categorisation.
The coverage rate of the North Rhine-Westphalian 
registry for the incidence and prevalence of type 2 diabetes 
in 11- to 18-year-old children and adolescents was estimated 
at 72% or 77%. The corresponding rates in the DPV data 
for North Rhine-Westphalia were 52% or 59%. The esti-
mates of national incidence and prevalence are therefore 
more uncertain than the estimates from North Rhine-West-
phalia.
For the surveys in Saxony and Baden-Württemberg no 
formal estimates of total coverage rate were possible. The 
figures in Saxony were adjusted based on the survey 
response rate and in Baden-Württemberg based on an ear-
lier estimate of the coverage rate [14]. Due to the anonymised 
data collection, double reporting could lead to an overes-
however, without full laboratory analysis, a clear distinction 
between type 1 diabetes and LADA often cannot be made. 
Therefore, it cannot be ruled out that a certain number of 
patients is categorised with the wrong diabetes type. How-
ever, the numbers of false categorisations are presumably 
so small that they do not relevantly influence incidence and 
prevalence estimates.
The coverage rate for new cases of type 1 diabetes in 
young adults aged 18 to 34 years was only 30%. The cov-
erage rate for the prevalence of type 1 diabetes in young 
adults was 73% and, hence, substantially higher. Therefore, 
a bias in the incidence estimates for North Rhine-West-
phalia cannot be entirely ruled out; prevalence estimates 
are to be considered as more valid.
The coverage rate of the DPV registry for type 1 diabetes 
could only be estimated for young adults (18- to 34-years-
old) using the data of the North Rhine-Westphalian regis-
try. In this case too, the coverage rate for incident cases 
(around 17%) were far lower than for prevalent cases 
(around 61%). Moreover, it should be noted that uncertain-
ties in the estimation of coverage rates were not consid-
ered when estimating adjusted incidences and prevalences.
For coverage rates at older ages, plausible assumptions 
on the completeness of capture of the DPV registry had to 
be made. For incident cases, the estimated coverage rate 
for young adults (18- to 34-years-old) was applied to older 
age groups, for prevalent cases a coverage rate of 15% was 
chosen. An underreporting of adult prevalent cases must 
already be expected, because prevalent type 1 diabetes 
cases at the age of e.g. over 26 in 2016, who therefore devel-
oped diabetes before 1990, were less likely to be registered 
due to the late start of registries (DPV mid 1990s, North 
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epidemiological parameters in the future and therefore 
also to assess trends over time. The provided data com-
plements the available epidemiological data on child and 
adolescent type 1 diabetes (three incidence registries in 
Baden-Württemberg, North Rhine-Westphalia and Saxony, 
as well as the national DPV registry) and on type 2 dia betes 
in adults (regional and national surveys, as well as anal-
yses of the data provided by statutory health insurances), 
so that diabetes surveillance can monitor the epidemiology 
of type 1 and type 2 diabetes across all age groups. For 
health policy and public health institutions this is key to 
planning future health care needs, and is also important 
for the interested public. Annually updating this data is 
furthermore important to assess whether prevention mea-
sures are effective at the population level.
To consolidate the diabetes surveillance, data on type 1 
diabetes in adults and type 2 diabetes in children and ado-
lescents should also be collected and evaluated in the com-
ing years. For the manifestation year 2018 this has already 
occurred (co-operation project 2019). A further perspective 
for the future of diabetes surveillance could be to expand 
the scope beyond type 1 and type 2 diabetes and include 
analyses of rare forms at national level which are neverthe-
less relevant for an overall evaluation of diabetes, such as 
genetic-based (for example MODY diabetes) or secondary 
diabetes forms (for example in mucoviscidosis patients) 
because valid epidemiological data on rare forms of dia-
betes cannot be collected through population-based rep-
resentative samples [46].
timation if the patient is treated simultaneously in a spe-
cialised diabetological practice and an outpatient clinic or 
if patients move. However, the determined case numbers 
probably underestimate the true prevalences. The estimates 
presented here are therefore only rough approximations.
4.3 Conclusion and outlook
Initially, the project ‘Type 1 diabetes in adults and type 2 
diabetes in children and adolescents’ focused on develop-
ing and providing methods and procedures to estimate the 
incidence and prevalence of type 1 diabetes at adult age 
and type 2 diabetes at child and adolescent age in close 
co-operation with the available local registries in 
Baden-Württemberg, North Rhine-Westphalia and Saxony, 
as well as the national DPV registry. For paediatric clinics 
(participants in the diabetes registries in Saxony and 
Baden-Württemberg) and diabetological clinics, surveys 
were established on treated child and adolescent type 2 
diabetes in Baden-Württemberg (prevalence) and newly 
diagnosed child and adolescent type 2 diabetes in Saxony 
(incidence). Furthermore, in a co-operation between the 
DPV registry Ulm and the diabetes registry in North 
Rhine-Westphalia, methods and procedures to estimate 
the national incidence and prevalence of type 1 diabetes in 
adults and type 2 diabetes in children and adolescents were 
provided. Gender-specific aspects were also taken into 
account.
The structures to estimate the national incidence and 
prevalence of type 1 diabetes in adults and type 2 diabetes 
in children and adolescents established by this project pro-
vide the basis for a continuous surveillance of these 
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